What This Top Dividend Portfolio Is Holding Now: AstraZeneca plc, HSBC Holdings plc And Vodafone Group plc

HSBC Holdings plc (LON:HSBA), AstraZeneca plc (LON:AZN) and Vodafone Group plc (LON:VOD) are heavyweight holdings of JP Morgan Claverhouse Investment Trust (LON:JCH).

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

JP Morgan Claverhouse IT (LSE: JCH) has a record of 41 consecutive years of dividend increases. At a current share price of 582p, the trust is on a trailing yield of 3.4%.

Picking great dividend shares has helped JP Morgan Claverhouse outperform the FTSE All-Share Index over the past three, five and 10 years.

Sectors in which the trust is currently overweight against the index include financials, healthcare and telecoms. The trust’s three biggest holdings in these three sectors are: HSBC (LSE: HSBA) (NYSE: HSBC.US), AstraZeneca (LSE: AZN) and Vodafone (LSE: VOD).

HSBC

Banking giant HSBC may have ditched its advertising slogan “The World’s Local Bank” a couple of years ago, but it has remained a convenient tag for financial hacks like me to emphasise the group’s global reach.

Geographical diversification helped HSBC get through the 2008/9 financial crisis. And while the company did reduce its dividend during those dark days, the payout has been growing at a good clip since, including a 9% rise for 2013.

City analysts are expecting a more modest 4% increase this year, followed by a 7% uplift for 2015. The recent market sell-off has seen HSBC’s shares hit a 52-week low of 589p, pushing the forward dividend yield up to a juicy 5.5% for investors today.

AstraZeneca

It’s been a good year for shareholders of AstraZeneca. The shares, which started the year at 3,600p, are currently trading at 4,427p on the back of the company’s strengthening drugs pipeline and management’s confident rejection of a 5,500p takeover offer from US pharma giant Pfizer.

The improving outlook hasn’t yet fed through to a rising dividend. Analysts are expecting the 2014 payout to be pegged at $2.80 for a fourth consecutive year, and for there to be little, if any, increase in 2015.

Nevertheless, the sterling translation of the dollar dividend equates to a yield of 4%, which is comfortably above the FTSE 100 average of 3.5%. And we could see the payout begin to rise pretty strongly further down the line.

Vodafone

Vodafone has been in a period of transition since selling its stake in US phones firm Verizon Wireless to Verizon Communications for £84bn earlier this year. The mobile giant’s earnings won’t — for at least a couple of years — cover the rising dividends the company hopes to pay.

Nevertheless, management reckons it can afford to lift the annual payouts, and signalled its confidence by raising the company’s recent interim dividend by 2%. If that carries through to the final dividend, as City analysts expect, we’d be looking at a forward yield of around 5.3% at a current share price of 213p.

G A Chester has no position in any shares mentioned. The Motley Fool UK has recommended HSBC Holdings. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Is 2026 the year the Diageo share price bounces back?

Will next year be the start of a turnaround for the Diageo share price? Stephen Wright looks at a key…

Read more »

Investing Articles

Here’s my top FTSE 250 pick for 2026

UK investors looking for under-the-radar opportunities should check out the FTSE 250. And 2026 could be an exciting year for…

Read more »

Yellow number one sitting on blue background
Investing Articles

Here’s my number 1 passive income stock for 2026

Stephen Wright thinks a 5.5% dividend yield from a company with a strong competitive advantage is something passive income investors…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

Should I sell my Scottish Mortgage shares in 2026?

After a strong run for Scottish Mortgage shares, our writer wonders if he should offload them to bank profits in…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Down 35%! These 2 blue-chips are 2025’s big losers. But are they the best shares to buy in 2026?

Harvey Jones reckons he's found two of the best shares to buy for the year ahead, but he also acknowledges…

Read more »

A senior man and his wife holding hands walking up a hill on a footpath looking away from the camera at the view. The fishing village of Polperro is behind them.
Investing Articles

State Pension worries? 3 investment trusts to target a £2.6m retirement fund

Royston Wild isn't worried about possible State Pension changes. Here he identifies three investment trusts to target a multi-million-pound portfolio.

Read more »

Smiling white woman holding iPhone with Airpods in ear
Dividend Shares

4 dirt-cheap dividend stocks to consider for 2026!

Discover four great dividend stocks that could deliver long-term passive income -- and why our writer Royston Wild thinks they’re…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

These fabulous 5 UK stocks doubled in 2025 – can they do it again next year?

These five UK stocks have more than doubled investors' money as the FTSE 100 surges. Harvey Jones wonders if they…

Read more »